Arax Advisory Partners’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-774
| Closed | -$61.2K | – | 4067 |
|
|
2025
Q4 | $61.2K | Buy |
+774
| New | +$58.3K | ﹤0.01% | 1512 |
|
|
2025
Q3 | – | Sell |
-156
| Closed | -$6.17K | – | 3951 |
|
|
2025
Q2 | $6.17K | Buy |
156
+52
| +50% | +$1.7K | ﹤0.01% | 2165 |
|
|
2025
Q1 | $3.14K | Hold |
104
| – | – | ﹤0.01% | 1942 |
|
|
2024
Q4 | $3.64K | Hold |
104
| – | – | ﹤0.01% | 1847 |
|
|
2024
Q3 | $4.17K | Hold |
104
| – | – | ﹤0.01% | 1792 |
|
|
2024
Q2 | $4.96K | Buy |
104
+79
| +316% | +$3.24K | ﹤0.01% | 1600 |
|
|
2024
Q1 | $1.08K | Sell |
25
-59
| -70% | -$2.81K | ﹤0.01% | 1141 |
|
|
2023
Q4 | $4.25K | Buy |
84
+44
| +110% | +$2.11K | ﹤0.01% | 914 |
|
|
2023
Q3 | $1.81K | Sell |
40
-58
| -59% | -$2.39K | ﹤0.01% | 1030 |
|
|
2023
Q2 | $4.02K | Buy |
98
+9
| +10% | +$346 | ﹤0.01% | 906 |
|
|
2023
Q1 | $3.18K | Buy |
89
+74
| +493% | +$2.78K | ﹤0.01% | 938 |
|
|
2022
Q4 | $567 | Sell |
15
-22
| -59% | -$925 | ﹤0.01% | 1166 |
|
|
2022
Q3 | $2K | Buy |
+37
| New | +$1.56K | ﹤0.01% | 961 |
|
|
2022
Q1 | – | Sell |
-38
| Closed | -$1K | – | 1176 |
|
|
2021
Q4 | $1K | Buy |
+38
| New | +$1.2K | ﹤0.01% | 1032 |
|
|
2020
Q1 | – | Sell |
-30
| Closed | -$2K | – | 699 |
|
|
2019
Q4 | $2K | Hold |
30
| – | – | ﹤0.01% | 552 |
|
|
2019
Q3 | $2K | Hold |
30
| – | – | ﹤0.01% | 553 |
|
|
2019
Q2 | $2K | Buy |
+30
| New | +$2.12K | ﹤0.01% | 553 |
|
|
2018
Q4 | $2K | Hold |
30
| – | – | ﹤0.01% | 528 |
|
|
2018
Q3 | $2K | Buy |
+30
| New | +$1.41K | ﹤0.01% | 572 |
|
Other funds holding IONS
VPM
VCM
